0000899243-18-027358.txt : 20181024
0000899243-18-027358.hdr.sgml : 20181024
20181024162247
ACCESSION NUMBER: 0000899243-18-027358
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181015
FILED AS OF DATE: 20181024
DATE AS OF CHANGE: 20181024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DAVIS STEPHEN
CENTRAL INDEX KEY: 0001131146
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 181136673
MAIL ADDRESS:
STREET 1: NEUROGEN CORP
STREET 2: 35 NORTHEAST INDUSTRIAL RD
CITY: BRANFORD
STATE: CT
ZIP: 06405
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-15
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001131146
DAVIS STEPHEN
3611 VALLEY CENTRE DRIVE, SUITE 300
SAN DIEGO
CA
92130
1
1
0
0
PRESIDENT AND CEO
Stock Option(right to buy)
21.28
2018-10-15
4
A
0
95000
0.00
A
2028-10-15
Common Stock
95000
95000
D
Restricted Stock Units
2018-10-15
4
A
0
23750
0.00
A
Common Stock
23750
23750
D
25% of the shares subject to the Stock Option vest and become exercisable on October 15, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
The restricted stock units vest in four equal annual installments beginning October 15, 2019.
/s/ Elizabeth N. Carter, Attorney-in-Fact
2018-10-24